Roche Win Boosts Case for Adding Chemo to Cancer Immunotherapy – Voice of America
Voice of America |
Roche Win Boosts Case for Adding Chemo to Cancer Immunotherapy
Voice of America Cancer doctors struggling to work out the best way to use modern immunotherapy drugs now have further evidence of the benefits of adding them to chemotherapy, despite earlier skepticism. News that Roche's immune system-boosting drug Tecentriq … Roche reshuffles lung cancer immunotherapy market with positive clinical trial results Roche chemo-immunotherapy combo mets NSCLC Phase III endpoint Roche gets $12 billion stock boost from positive cancer, hemophilia results |
